Published 3 years ago • loading... • Updated 3 years ago

Illumina Wins Case Against FTC on Grail Acquisition

Summary by Ground News

The Federal Trade Commission has rejected a bid by Illumina to buy the early cancer detection company Grail. The San Diego-based company acquired Grail for $8 billion last year. Grail detects DNA sequence changes, chemical modifications, or other changes through a simple blood draw. The technology can detect a wide range of cancer types.

10 Articles

All

Left

Center

Right

Financial Post

Lean Right

U.S. judge backs Illumina deal for Grail in blow to FTC

WASHINGTON -- A U.S. administrative judge has ruled in favor of Illumina Inc's acquisition of cancer detection test maker Grail Inc, the U.S. maker of genetic analysis equipment said on Thursday. Read More

3 years ago·Canada

Read Full Article

Times of San Diego

Center

Administrative Law Judge Rules in Favor of Illumina in FTC Challenge to Grail Deal

Pioneering San Diego genomics leader Illumina announced Thursday that an administrative law judge had cleared its acquisition of spinoff cancer detection test maker Grail.

3 years ago·San Diego County, United States

Read Full Article

STAT

Center

Illumina wins case against FTC in bid to hold onto early cancer detection company Grail

Sequencing behemoth Illumina won its case against the FTC in its bid to hold onto Grail, a Bay Area early cancer detection company.

3 years ago·Boston, United States

Read Full Article

KELO Newstalk 1320 107.9

Right

Illumina wins case against U.S. FTC on Grail purchase – WSJ

(Reuters) - A judge has ruled in favor of Illumina Inc in its acquisition of Grail Inc dealing a blow to the U.S. Federal Trade Commission's efforts t...

3 years ago

Read Full Article

Investing.com

Center

Illumina wins case against U.S. FTC on Grail purchase - WSJ By Reuters

Illumina wins case against U.S. FTC on Grail purchase - WSJ

3 years ago

Read Full Article

Bloomberg

Lean Left

Illumina Wins Case Against FTC on Grail Acquisition

Illumina Inc. won a US Federal Trade Commission lawsuit seeking to unwind its $7 billion acquisition of cancer-startup Grail Inc. after an administrative judge ruled the tie-up didn’t violate antitrust law, the company said.

3 years ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year